Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-004892

Options or other derivatives

  • Director acquired 4,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
FOLLMAN ROBERT J Director 2016-04-07 Grant or award · 5% Secured Convertible Note due December 2017 +0 I
FOLLMAN ROBERT J Director 2016-04-07 Grant or award · Common Stock Warrant +4,000,000 9,000,000 I
Loading xslF345X03/s103000_form4.xml…